Editorial| Volume 119, ISSUE 4, P403-406, 2007

From red wine to polyphenols and back: A journey through the history of the French Paradox

  • D.W. de Lange
    Tel.: +31 30 2503037; fax: +31 30 2503261.
    Thrombosis and Hemostasis Laboratory, University Medical Center, Heidelberglaan 100, Room Q04.4.307, P.O. Box 35500, 3584 CX Utrecht, The Netherlands
    Search for articles by this author
      Soleas et al. pointed out that the first written account of wine consumption and prolonged existence stems from the Bible [
      • Soleas G.J.
      • Diamandis E.P.
      • Goldberg D.M.
      Wine as a biological fluid: history, production, and role in disease prevention.
      ]. The world's fauna had been just annihilated by the Great Flood when wine came into existence. When Noah's ark stranded on dry land and when the waters receded, human agriculture commenced with Noah's establishment of a vineyard (Genesis, Chapter IX, verse 20–29). Noah clearly enjoyed his own winemaking as he lay naked and drunk in his tent. However, his drunkenness did not affect his longevity for he lived another three hundred and fifty years.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Thrombosis Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Soleas G.J.
        • Diamandis E.P.
        • Goldberg D.M.
        Wine as a biological fluid: history, production, and role in disease prevention.
        J Clin Lab Anal. 1997; 11: 287-313
        • McGovern P.E.
        • Glisker D.L.
        • Exner L.J.
        • Voigt M.M.
        Neolithic resinated wine.
        Nature. 1996; 381: 480-481
        • Renaud S.
        • de Lorgeril M.
        Wine, alcohol, platelets, and the French paradox for coronary heart disease.
        Lancet. 1992; 339: 1523-1526
        • Law M.
        • Wald N.
        Why heart disease mortality is low in France: the time lag explanation.
        BMJ. 1999; 318: 1471-1476
        • Jackson R.
        • Broad J.
        • Connor J.
        • Wells S.
        Alcohol and ischaemic heart disease: probably no free lunch.
        Lancet. 2005; 366: 1911-1912
        • de Lange D.W.
        • van de Wiel A.
        Drink to prevent: review on the cardioprotective mechanisms of alcohol and red wine polyphenols.
        Semin. Vasc. Med. 2004; 4: 173-186
        • Naimi T.S.
        • Brown D.W.
        • Brewer R.D.
        • Giles W.H.
        • Mensah G.
        • Serdula M.K.
        • et al.
        Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U.S. adults.
        Am J Prev Med. 2005; 28: 369-373
        • Rehm J.
        • Greenfield T.K.
        • Rogers J.D.
        Average volume of alcohol consumption, patterns of drinking, and all-cause mortality: results from the US National Alcohol Survey.
        Am J Epidemiol. 2001; 153: 64-71
        • Pletcher M.J.
        • Varosy P.
        • Kiefe C.I.
        • Lewis C.E.
        • Sidney S.
        • Hulley S.B.
        Alcohol consumption, binge drinking, and early coronary calcification: findings from the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
        Am J Epidemiol. 2005; 161: 423-433
        • Al Awwadi N.A.
        • Borrot-Bouttefroy A.
        • Umar A.
        • Segur M.C.
        • Garreau C.
        • Saucier C.
        • et al.
        Effect of Armagnac fractions on human platelet aggregation in vitro and rat arteriovenous shunt thrombosis in vivo probably not related only to polyphenols.
        Thromb Res. 2006; 117 ([Please, edit this reference to suit the Journal])
        • Di Castelnuovo A.
        • Rotondo S.
        • Iacoviello L.
        • Donati M.B.
        • de Gaetano G.
        Meta-analysis of wine and beer consumption in relation to vascular risk.
        Circulation. 2002; 105: 2836-2844
        • Donovan J.L.
        • Bell J.R.
        • Kasim-Karakas S.
        • German J.B.
        • Walzem R.L.
        • Hansen R.J.
        • et al.
        Catechin is present as metabolites in human plasma after consumption of red wine.
        J Nutr. 1999; 129: 1662-1668
        • Umar A.
        • Depont F.
        • Jacquet A.
        • Lignot S.
        • Segur M.C.
        • Boisseau M.
        • et al.
        Effects of armagnac or vodka on platelet aggregation in healthy volunteers: a randomized controlled clinical trial.
        Thromb Res. 2005; 115: 31-37
        • Shanmuganayagam D.
        • Beahm M.R.
        • Osman H.E.
        • Krueger C.G.
        • Reed J.D.
        • Folts J.D.
        Grape seed and grape skin extracts elicit a greater antiplatelet effect when used in combination than when used individually in dogs and humans.
        J Nutr. 2002; 132: 3592-3598
        • Manach C.
        • Williamson G.
        • Morand C.
        • Scalbert A.
        • Remesy C.
        Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies.
        Am J Clin Nutr. 2005; 81: 230S-242S
        • de Vries J.H.
        • Hollman P.C.
        • van A I.
        • Olthof I.
        • Katan M.R.
        Red wine is a poor source of bioavailable flavonols in men.
        J Nutr. 2001; 131: 745-748
        • de Lange D.W.
        • Hijmering M.L.
        • Lorsheyd A.
        • Scholman W.L.
        • Kraaijenhagen R.J.
        • Akkerman J.W.
        • et al.
        Rapid intake of alcohol (binge drinking) inhibits platelet adhesion to fibrinogen under flow.
        Alcohol Clin Exp Res. 2004; 28: 1562-1568